Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.

MLA

Grosse, Scott D., et al. “Estimates of Utility Weights in Hemophilia: Implications for Cost-Utility Analysis of Clotting Factor Prophylaxis.” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 15, no. 2, Apr. 2015, pp. 267–83. EBSCOhost, https://doi.org/10.1586/14737167.2015.1001372.

APA

Grosse, S. D., Chaugule, S. S., & Hay, J. W. (2015). Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis. Expert Review of Pharmacoeconomics & Outcomes Research, 15(2), 267–283. https://doi.org/10.1586/14737167.2015.1001372

Chicago

Grosse, Scott D, Shraddha S Chaugule, and Joel W Hay. 2015. “Estimates of Utility Weights in Hemophilia: Implications for Cost-Utility Analysis of Clotting Factor Prophylaxis.” Expert Review of Pharmacoeconomics & Outcomes Research 15 (2): 267–83. doi:10.1586/14737167.2015.1001372.